After 10 years of living with a special device that helps the heart pump blood, one pediatric patient is part of an elite group of survivors.
Anxious to protect her children, Stanford immunology researcher enrolls her two young children Pfizer’s COVID-19 vaccine clinical trial for kids.
A revolutionaly technique helps cure 9-year-old girl who was Stanford Children's Health's 1,000th stem cell transplant patient.
A cancer survivor treated at Stanford has written a book to help kids facing stem cell transplant understand the procedure and approach it with courage.
In this Voices of COVID story, Stanford Children's Health physician Alan Schroeder, MD, talks about his work caring for kids with COVID-19 symptoms.
Tracking a pain-relief device's success in patients who aren't in clinical trials is seen as a promising approach to expanding treatment options for kids.
A blood test that predicts if a baby will be born prematurely works well for pregnant women in developing countries, a Stanford-led study found.
A public health program in India improved maternal and child health initially, but was at risk of leaving behind disadvantaged participants when it expanded.
Stanford researchers have several projects underway to improve imaging techniques, bracing treatment and surgeries for kids and teens with scoliosis.
A Stanford researcher talks about navigating the uncertainty of making medical decisions for her 5-year-old son with an undiagnosed genetic disorder.
Stanford infectious disease expert Yvonne Maldonado, MD, describes principles for developing safe and effective COVID-19 vaccines for everyone.
Technology that sends blood sugar-level updates to their smartphones improves outcomes for young people with type 1 diabetes, a Stanford trial shows.
With changes in ultrasound technology, Stanford researchers have improved the method of diagnosing brain bleeds, a common form of birth injury in newborns.
When pregnant women are assaulted, their babies are more likely to be born prematurely and to weigh less, Stanford Health Policy research shows.
A Stanford physician co-authored a list of likely biological factors underlying the reduced development of COVID-19 for children compared to adults.
Stanford researchers have found a good drug target for treating Diamond-Blackfan anemia, a genetic disease that impairs red blood cell formation.